20/20 Biolabs, Inc.
AIDX
$0.53
$0.012.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 344.00% | 136.50% | -42.49% | -- | -- |
| Total Receivables | 67.24% | -- | 47.82% | -- | -- |
| Inventory | 79.90% | -- | 146.19% | -- | -- |
| Prepaid Expenses | -16.94% | -- | 90.27% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 259.26% | -- | -27.68% | -- | -- |
|
|
|||||
| Total Current Assets | 259.26% | -- | -27.68% | -- | -- |
| Net Property, Plant & Equipment | -28.61% | -- | -25.54% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.04% | -- | -5.17% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | 845.00% | -- | -- |
| Total Assets | 127.06% | -- | 15.43% | -- | -- |
|
|
|||||
| Total Accounts Payable | 84.48% | -- | 133.28% | -- | -- |
| Total Accrued Expenses | 60.90% | -- | 126.72% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.82% | -- | 51.24% | -- | -- |
| Total Finance Division Other Current Liabilities | 22.73% | -- | 18.66% | -- | -- |
| Total Other Current Liabilities | 22.73% | -- | 18.66% | -- | -- |
| Total Current Liabilities | 55.06% | -- | 81.77% | -- | -- |
|
|
|||||
| Total Current Liabilities | 55.06% | -- | 81.77% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.79% | -- | -27.47% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -28.17% | -- | 1,070.80% | -- | -- |
| Total Liabilities | 26.39% | -- | 99.94% | -- | -- |
|
|
|||||
| Common Stock & APIC | 24.38% | -- | 7.05% | -- | -- |
| Retained Earnings | -20.33% | -- | -12.67% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 432.42% | 75.01% | -104.55% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3,159.75% | -- | 0.85% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3,159.75% | 336.32% | 0.85% | -- | -- |
|
|
|||||
| Total Common Equity | 432.42% | 75.01% | -104.55% | -- | -- |
| Total Preferred Equity | 3,159.75% | 336.32% | 0.85% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 798.55% | 83.14% | -101.28% | -- | -- |
|
|
|||||